Business Context and Reporting Period
Company: Intrusion Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: Intrusion Inc. develops and markets network security, data privacy, and compliance products, including TraceCop, Compliance Commander, and SecureNet. The company serves government entities, financial institutions, and healthcare providers. It is currently transitioning its product focus from SecureNet to Compliance Commander and TraceCop.
Key Financial Metrics
| Metric (in thousands) | Q1 2008 | Q1 2007 |
|---|---|---|
| Total Revenue | $462 | $1,092 |
| Gross Profit | $283 | $671 |
| Gross Margin | 61.2% | 61.4% |
| Operating Loss | $(869) | $(494) |
| Net Loss | $(875) | $(492) |
| Net Loss Attributable to Common | $(915) | $(535) |
| Cash and Equivalents (End of Period) | $93 | $682 |
| Working Capital | $(1,305) | $500 (Surplus) |
| Accumulated Deficit | $(58,347) | $(57,472) |
Liquidity Position: As of March 31, 2008, the company held $93,000 in cash. It has a $1.0 million line of credit with $14,000 outstanding and $31,000 available. Additionally, the CEO has a written commitment to invest up to $1.5 million if necessary.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 57.7% year-over-year, dropping from $1.1 million to $0.5 million. Product revenue fell $0.6 million due to the strategic shift away from SecureNet and delays in government funding for TraceCop projects.
- Increased Losses: Net loss widened by 77.8% to $0.9 million. Operating expenses increased as a percentage of revenue, particularly Research and Development (111.5% of revenue vs. 38.7% in 2007) and Sales and Marketing (80.3% vs. 47.1%).
- Cash Burn: Cash used in operating activities increased to $0.9 million from $0.6 million. Cash balances dropped from $362,000 at year-end 2007 to $93,000 at March 31, 2008.
- Debt Structure: The company borrowed $705,000 from an officer (CEO) during the quarter to fund operations, recorded as "Loans payable to officer."
Outlook, Risks, and Management Commentary
Management Commentary: Management expects product revenue to increase in the future as market acceptance of Compliance Commander and TraceCop grows. However, they anticipate net operating losses and cash outflows to continue through the second quarter of 2008 and possibly later in the fiscal year.
Key Risks and Contingencies:
- Liquidity Risk: The company faces a significant working capital deficiency of $1.3 million. Continued operations depend on generating positive cash flow or securing additional debt/equity financing, which may result in significant dilution.
- Preferred Stock Dividends: The company is obligated to pay accrued dividends on three series of preferred stock. Failure to pay may trigger late fees (18% per annum) or forced redemption of preferred shares for common stock, causing massive dilution (potentially 184.6% increase in shares).
- Customer Concentration: 59.6% of Q1 2008 revenue came from U.S. government entities. Delays in government funding or contract cancellations pose a material risk.
- Product Transition: The company is in a developmental stage regarding its new product lines. There is no assurance that new products will achieve market acceptance sufficient to offset the decline in legacy product sales.
Investor Verification Checklist
- Cash Runway: Verify if the $93,000 cash balance plus the $31,000 credit line availability is sufficient to cover operating expenses until the next funding event.
- CEO Loan Terms: Review the terms of the $705,000 loan from the CEO and the $1.5 million investment commitment to understand repayment schedules and conversion rights.
- Preferred Stock Accruals: Confirm the total accrued but unpaid dividends on Series 1, 2, and 3 preferred stock and the potential dilution impact if redemption is triggered.
- Government Contract Status: Investigate the status of the delayed government funding for TraceCop projects expected in Q2 2008.
- Revenue Mix: Monitor the ratio of revenue from new products (Compliance Commander/TraceCop) versus legacy products to assess the success of the strategic pivot.